NDC 71244-375
This exact product or package identity exists in FDA auxiliary data but is not present in the current primary NDC product table. The package identity is preserved; status rows are reported source observations, not medical conclusions.
- Requested NDC
- 71244-375
- Product root
- 71244-375
- Identity scope
- Product
- Primary current NDC product row
- Not present
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| compounder | package | 71244-375 | 71244-375-20 | COMPOUNDER | Outsourcing facility compounded drug report | 2019-2 | 2026-10-24 |
| compounder | package | 71244-375 | 71244-375-17 | COMPOUNDER | Outsourcing facility compounded drug report | 2019-2 | 2026-10-24 |
| compounder | package | 71244-375 | 71244-375-15 | COMPOUNDER | Outsourcing facility compounded drug report | 2019-2 | 2026-10-24 |
| compounder | package | 71244-375 | 71244-375-12 | COMPOUNDER | Outsourcing facility compounded drug report | 2019-2 | 2026-10-24 |
| compounder | package | 71244-375 | 71244-375-10 | COMPOUNDER | Outsourcing facility compounded drug report | 2019-2 | 2026-10-24 |
| compounder | package | 71244-375 | 71244-375-08 | COMPOUNDER | Outsourcing facility compounded drug report | 2019-2 | 2026-10-24 |
| compounder | package | 71244-375 | 71244-375-17 | COMPOUNDER | Outsourcing facility compounded drug report | 2019-1 | 2026-10-24 |
| compounder | package | 71244-375 | 71244-375-12 | COMPOUNDER | Outsourcing facility compounded drug report | 2019-1 | 2026-10-24 |
| compounder | package | 71244-375 | 71244-375-08 | COMPOUNDER | Outsourcing facility compounded drug report | 2019-1 | 2026-10-24 |
| compounder | package | 71244-375 | 71244-375-15 | COMPOUNDER | Outsourcing facility compounded drug report | 2019-1 | 2026-10-24 |
| compounder | package | 71244-375 | 71244-375-20 | COMPOUNDER | Outsourcing facility compounded drug report | 2019-1 | 2026-10-24 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Package NDC | Reporting period |
|---|---|
| 71244-375-08 | 2019-2 |
| 71244-375-20 | 2019-2 |
| 71244-375-15 | 2019-2 |
| 71244-375-17 | 2019-2 |
| 71244-375-10 | 2019-2 |
| 71244-375-12 | 2019-2 |
| 71244-375-17 | 2019-1 |
| 71244-375-12 | 2019-1 |
| 71244-375-20 | 2019-1 |
| 71244-375-15 | 2019-1 |
| 71244-375-08 | 2019-1 |
Compounder NDC reports#
| Establishment | FEI | Product NDC | Package NDC | Product | Active ingredients | Reporting period | Normalization |
|---|---|---|---|---|---|---|---|
| "Pentec Health, Inc(080215699)" | 71244-375 | 71244-375-08 | Vancomycin Hydrochloride | 100 mg/1 mL | 2019-2 | valid | |
| "Pentec Health, Inc(080215699)" | 71244-375 | 71244-375-10 | Vancomycin Hydrochloride | 100 mg/1 mL | 2019-2 | valid | |
| "Pentec Health, Inc(080215699)" | 71244-375 | 71244-375-12 | Vancomycin Hydrochloride | 100 mg/1 mL | 2019-2 | valid | |
| "Pentec Health, Inc(080215699)" | 71244-375 | 71244-375-15 | Vancomycin Hydrochloride | 100 mg/1 mL | 2019-2 | valid | |
| "Pentec Health, Inc(080215699)" | 71244-375 | 71244-375-17 | Vancomycin Hydrochloride | 100 mg/1 mL | 2019-2 | valid | |
| "Pentec Health, Inc(080215699)" | 71244-375 | 71244-375-20 | Vancomycin Hydrochloride | 100 mg/1 mL | 2019-2 | valid | |
| "Pentec Health, Inc(080215699)" | 71244-375 | 71244-375-08 | Vancomycin Hydrochloride | 100 mg/1 mL | 2019-1 | valid | |
| "Pentec Health, Inc(080215699)" | 71244-375 | 71244-375-12 | Vancomycin Hydrochloride | 100 mg/1 mL | 2019-1 | valid | |
| "Pentec Health, Inc(080215699)" | 71244-375 | 71244-375-15 | Vancomycin Hydrochloride | 100 mg/1 mL | 2019-1 | valid | |
| "Pentec Health, Inc(080215699)" | 71244-375 | 71244-375-17 | Vancomycin Hydrochloride | 100 mg/1 mL | 2019-1 | valid | |
| "Pentec Health, Inc(080215699)" | 71244-375 | 71244-375-20 | Vancomycin Hydrochloride | 100 mg/1 mL | 2019-1 | valid |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.